Historical salary details - Mr. Berndt Modig, Chief Executive Officer and Executive Director, Pharvaris NV
Mr. Berndt Modig is the Chief Executive Officer and Executive Director of Pharvaris NV.
Mr. Berndt Modig
Chief Executive Officer and Executive Director
-
Gross Remuneration
-
Current Company
Pharvaris NV
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Pharvaris NV | Chief Executive Officer and Executive Director | - | - |
| 2023 | Pharvaris NV | - | 935.3 K | 19.5 % |
| 2023 | Centogene NV | Member of the Supervisory Board | 96 K | -32.4 % |
| 2022 | Pharvaris NV | Chief Executive Officer and Executive Director | 782.8 K | 8.5 % |
| 2022 | Centogene NV | Member of the Supervisory Board | 142 K | - |
| 2021 | Pharvaris NV | Chief Executive Officer and Executive Director | 721.6 K | - |
| 2021 | Centogene NV | Member of the Supervisory Board | - | - |
| 2020 | Centogene NV | Member of the Supervisory Board | 120 K | 60.0 % |
| 2020 | Affimed N.V. | Member of the Supervisory Board | 34 K | -58.0 % |
| 2020 | Pharvaris NV | Chief Executive Officer and Executive Director | - | - |
| 2019 | Affimed N.V. | Member of the Supervisory Board | 81 K | 20.9 % |
| 2019 | Centogene NV | Member of the Supervisory Board | 75 K | 44.2 % |
| 2018 | Affimed N.V. | Member of the Supervisory Board | 67 K | -5.6 % |
| 2018 | Centogene NV | Member of the Supervisory Board | 52 K | - |
| 2018 | Altamira Therapeutics Ltd | - | 9.8 K | -85.4 % |
| 2017 | Affimed N.V. | Member of the Supervisory Board | 71 K | 42.0 % |
| 2017 | Altamira Therapeutics Ltd | Director | 67.3 K | - |
| 2016 | Affimed N.V. | Member of the Supervisory Board | 50 K | 35871.2 % |
| 2016 | Altamira Therapeutics Ltd | Independent Director | - | - |
| 2015 | Affimed N.V. | Member of the Supervisory Board | 139.0 | -99.5 % |
| 2015 | Altamira Therapeutics Ltd | Independent Director | - | - |
| 2014 | Affimed N.V. | Member of the Supervisory Board | 27 K | - |
| 2013 | Affimed N.V. | Director | - | - |